ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
International Stem Cell CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026
- Market cap
- $2.27M
- P/E (TTM)
- –
- Dividend yield
- –
International Stem Cell CORP revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedical Market [Member] | $2.52M | $2.17M | $2.00M | $2.20M | $2.30M | $2.00M | $2.25M | $2.00M | $2.12M | $1.92M | $1.59M | $1.79M | 94.4% | +9.6% |
| Anti-aging Market [Member] | $151.00K | $145.00K | $155.00K | $165.00K | $144.00K | $134.00K | $199.00K | $179.00K | $211.00K | $206.00K | $302.00K | $188.00K | 5.6% | +4.9% |
| Anti-Aging Skincare Market [Member] | $151.00K | $145.00K | $155.00K | $165.00K | $144.00K | $134.00K | $199.00K | $179.00K | $211.00K | $206.00K | $302.00K | $188.00K | 5.6% | +4.9% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedical Market [Member] | $735.00K | $590.00K | $464.00K | $748.00K | $900.00K | $665.00K | $795.00K | $637.00K | $858.00K | $700.00K | $365.00K | $661.00K | -18.3% |
| Anti-aging Market [Member] | -$91.00K | -$103.00K | -$125.00K | -$88.00K | -$89.00K | -$208.00K | -$130.00K | -$125.00K | -$151.00K | -$196.00K | -$74.00K | -$138.00K | +2.2% |
| Therapeutic Market [Member] | -$679.00K | -$677.00K | -$652.00K | -$566.00K | -$644.00K | -$672.00K | -$614.00K | -$602.00K | -$558.00K | -$682.00K | -$715.00K | -$620.00K | +5.4% |
By product or service
By region
From the segment and revenue-disaggregation notes of International Stem Cell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.